Skin Biopsy Market Poised to Cross US$181.6 Million by 2031: A CAGR of 6%

According to the report published by Allied Market Research, the global skin biopsy market was valued at $101.2 million in 2021, and is projected to reach $181.58 million by 2031, registering a CAGR of 6% from 2022 to 2031. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

• The punch biopsy segment is expected to maintain its dominance by 2031 with a highest CAGR during the forecast period.
• The skin cancer segment is anticipated to grow at a fastest CAGR during the forecast period.
• Diagnostic laboratories segment is anticipated to grow at a fastest CAGR during the forecast period.

Request Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/13800

Major Factors Driving the Growth of Skin Biopsy Market:

• Rising prevalence of skin diseases: Skin diseases are a major global health concern, affecting millions of people worldwide. The prevalence of skin diseases is increasing due to a number of factors, including environmental pollution, changes in lifestyle, and aging. Skin biopsies are an essential tool for diagnosing skin diseases.
• Increasing demand for minimally invasive procedures: Minimally invasive procedures are becoming increasingly popular, as they offer patients a number of benefits, such as shorter recovery times and less pain. Skin biopsies are a minimally invasive procedure that can be performed quickly and easily in a doctor’s office.
• Technological advancements: Technological advancements have led to the development of new and improved skin biopsy devices. These devices are more accurate and less painful than traditional skin biopsy devices.
• Growing awareness of skin cancer: Skin cancer is the most common type of cancer in the United States. Skin biopsies are an essential tool for diagnosing skin cancer early on, when it is most treatable.
• Aging population: The global population is aging, and older adults are more likely to develop skin diseases. This is driving the demand for skin biopsies among the geriatric population.
• Increasing demand for personalized medicine: Personalized medicine is an approach to healthcare that takes into account the individual characteristics of each patient. Skin biopsies can be used to collect tissue samples that can be used to develop personalized treatment plans for skin diseases.

Market Segmentation:

By type:

• Shave biopsy: This is the most common type of skin biopsy, and it is used to remove a thin layer of skin.
• Punch biopsy: This type of biopsy is used to remove a small, round piece of skin.
• Excisional biopsy: This type of biopsy is used to remove a larger piece of skin, or an entire lesion.
• Incisional biopsy: This type of biopsy is used to remove a piece of tissue from a larger lesion.

By device:

• Needle-based biopsy guns: These devices are used to take core biopsies, which are small, cylindrical samples of tissue.
• Biopsy curettes and punches: These devices are used to take shave and punch biopsies.
• Guidance systems: These devices are used to guide biopsy needles to the correct location in the skin.
• Biopsy forceps: These devices are used to hold and remove tissue samples.
• Biopsy needles: These devices are used to take core biopsies.

By indication:

• Actinic keratosis: This is a precancerous skin condition that can be diagnosed with a skin biopsy.
• Dermatitis: This is a group of inflammatory skin conditions that can be diagnosed with a skin biopsy.
• Psoriasis: This is a chronic skin condition that can be diagnosed with a skin biopsy.
• Skin infection: This is an infection of the skin that can be diagnosed with a skin biopsy.
• Skin cancer: This is a type of cancer that can be diagnosed with a skin biopsy.

By end user:

• Hospitals: Hospitals are the most common setting for skin biopsies.
• Clinics: Clinics are also a common setting for skin biopsies.
• Dermatologists’ offices: Dermatologists are physicians who specialize in skin diseases, and they often perform skin biopsies in their offices.
• Ambulatory surgical centers: Ambulatory surgical centers are outpatient facilities that perform surgery, including skin biopsies.

By region:

• North America  (U.S., Canada, Mexico)
• Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
• LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Request for Customization: 

https://www.alliedmarketresearch.com/request-for-customization/13800

Regional Growth Dynamics:

North America held the major share in 2021, and garnered more than two-fifth of the global skin biopsy market revenue. Asia-Pacific, simultaneously, is anticipated to grow at a fastest CAGR from 2022 to 2031.

Competitive Landscape:

• KAI Group, AccuTec, Inc.
• Becton, Dickinson and Company
• Vernacare, Innovia Medical
• Jai Surgicals Ltd.
• Integra LifeSciences
• Paramount Surgimed Limited
• World Precision Instruments
• Cardinal Health Inc.

Some examples of business expansion in the market

In June 2020, Innovia Medical announced the increase in manufacturing capacity of cervical rotating biopsy punch to meet increased cancer diagnosis.

Table of Content:

CHAPTER 1: INTRODUCTION

• • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter’s five forces analysis
  • 3.3.1. Moderate bargaining power of suppliers
  • 3.3.2. Moderate bargaining power of buyers
  • 3.3.3. Moderate threat of substitutes
  • 3.3.4. Moderate threat of new entrants
  • 3.3.5. Moderate intensity of rivalry…………

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/13800

Key Questions Answered in the Intelligent Study

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

Why Choose Allied Market Research?

Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update

Market Dynamics and Transformations

Economic Downturn Analysis: Impact of Recession in 2023
Pandemic’s Influence: Impact of Covid-19 Pandemic
Market Evolution: Recent Developments in the Market with Key Players Announcements

Similar Research Reports for Information, Communication, and Technology:

Cell Line and Membrane Market: https://www.alliedmarketresearch.com/cell-line-and-membrane-market-A13858

Thyroid Ablation Devices Market: https://www.alliedmarketresearch.com/thyroid-ablation-devices-market-A13571

Hydrocephalus Market: https://www.alliedmarketresearch.com/hydrocephalus-market-A14991

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.